Life Science Leader Magazine Supplements

CRO Leadership Awards 2014

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link:

Contents of this Issue


Page 30 of 45

QUALITY RELIABILITY PRODUCTIVITY REGULATORY INNOVATION K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M 2014 CRO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2014 29 DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical (Phase 1) DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) MAIN SERVICE AREAS: Bioanalytical, Preclinical MAIN SERVICE AREAS: Clinical MAIN SERVICE AREAS: Bioanalytical, Clinical, Preclinical "MPI Research is honored to be recognized as an industry leader in multiple areas. This distinction represents the voice of our sponsors and is a testament to the knowledge and experience of our scientific team. Each and every employee strives to not only meet — but also to exceed — the expectations of our sponsors as we work together in providing healthcare solutions. We are pleased that, with these awards, our sponsors recognize our commitment to them." "The drug development process is a journey with many challenges, and PAREXEL has evolved to meet these complex changes and help bring these important new drugs to market, efficiently and reliably. Navigating regulatory constraints, patient recruitment challenges, data collection, and payer demands is increasingly complex. PAREXEL's goal is to help biopharmaceutical companies create and build the shortest journey from science to new treatments." "PPD's innovative solutions bend the cost and time curve of drug discovery and development to create value for biopharmaceutical clients, resulting in the delivery of life-changing therapies in a faster, more cost-effective manner. Our clients benefit from PPD's world-class scientific expertise, innovative technology, flexible service models, and operational efficiencies at every stage of the drug discovery and development continuum. We recognize that developing, engaging, and empowering our employees are keys to successful performance for our clients. Our people truly make the difference." SERVICES & CAPABILITIES: Comprehensive safety and efficacy drug development (small and large molecule) and medical device research, from discovery and preclinical through early clinical; environmental, food safety, and chemical testing; world-renowned anatomical/clinical pathology THERAPEUTIC AREAS: Metabolic disease, cardiovascular, orthopedic, renal, neurosciences, inflammation, infectious disease, oncology, ophthalmology SERVICES & CAPABILITIES: PAREXEL offers worldwide regulatory expertise, Phase I-IV clinical research services, eClinical technologies that accelerate development, and integrated commercialization services. The company delivers best-practice outsourcing models focused on significant value creat ion. THERAPEUTIC AREAS: PAREXEL has expertise across a broad range of therapeutic areas including oncology, cardiology, neurology, metabolism/endocrine, and infectious disease. SERVICES & CAPABILITIES: Preclinical: discovery (BioDuro and X-Chem), nonclinical; Clinical: Phase I, Phase II-IIIb and post-approval; therapeutic and specialty expertise; clinical data management/IT; consulting; Laboratory Services — bioanalytical labs; cGMP labs; central labs; vaccines and biologics THERAPEUTIC AREAS: Cardiovascular, critical care, dental pain research, dermatology, endocrine and metabolic, gastroenterology, hematology and oncology, immunology, infectious diseases, neuroscience, ophthalmology, respiratory, urology WILLIAM U. PARFET chairman and CEO JOSEF VON RICKENBACH chairman and CEO WILLIAM SHARBAUGH chief operating officer CATEGORIES WON CATEGORIES WON CATEGORIES WON PPD Wilmington, NC +1 910 251 0081 Key locations: Austin, TX; Research Triangle Park, NC; Richmond, VA; Wilmington, NC; China, Russia, Singapore, United Kingdom PAREXEL International Corporation Waltham, MA +1 781 487 9900 Diana Martin Key locations: Africa, Asia Pacific, China, Europe, Middle East, South America, United States MPI Research Mattawan, MI +1 269 668 3336 2 0 1 4 L S L C R O C o m p a n y P r o f i l e L a y o u t T h a t N i c e . i n d d 1 1 2014 LSL CRO Company Profile Layout That Nice.indd 11 2 / 2 2 / 2 0 1 4 1 : 4 2 : 2 6 P M 2/22/2014 1:42:26 PM

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2014